CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
Common Stock |
Treasury Shares |
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
|
Beginning balance (in shares) at Dec. 31, 2019 |
|
|
53,045,510
|
|
|
|
|
|
Beginning balance at Dec. 31, 2019 |
$ 262,386
|
|
$ 53,046
|
$ 0
|
$ 289,344
|
$ (7,961)
|
$ (72,043)
|
|
Beginning balance (in shares) at Dec. 31, 2019 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Net income (loss) |
24,249
|
|
|
|
|
|
24,249
|
|
Other comprehensive income (loss) |
4,787
|
|
|
|
|
4,787
|
|
|
Ending balance (in shares) at Dec. 31, 2020 |
|
|
53,045,510
|
|
|
|
|
|
Ending balance at Dec. 31, 2020 |
291,422
|
|
$ 53,046
|
$ 0
|
289,344
|
(3,174)
|
(47,794)
|
|
Ending balance (in shares) at Dec. 31, 2020 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Shareholders’ capital distributions |
(60,000)
|
|
|
|
(60,000)
|
|
|
|
Share-based compensation |
156
|
|
|
|
156
|
|
|
|
Net income (loss) |
20,629
|
|
|
|
|
|
20,629
|
|
Other comprehensive income (loss) |
236
|
|
|
|
|
236
|
|
|
Ending balance (in shares) at Nov. 08, 2021 |
|
|
53,045,510
|
|
|
|
|
|
Ending balance at Nov. 08, 2021 |
$ 252,443
|
|
$ 53,046
|
$ 0
|
229,500
|
(2,938)
|
(27,165)
|
|
Ending balance (in shares) at Nov. 08, 2021 |
|
|
|
0
|
|
|
|
|
Accounting Standards Update [Extensible Enumeration] |
Accounting Standards Update 2016-13 [Member]
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
|
53,045,510
|
|
|
|
|
|
Beginning balance at Dec. 31, 2020 |
$ 291,422
|
|
$ 53,046
|
$ 0
|
289,344
|
(3,174)
|
(47,794)
|
|
Beginning balance (in shares) at Dec. 31, 2020 |
|
|
|
0
|
|
|
|
|
Ending balance (in shares) at Dec. 31, 2021 |
157,237,435
|
|
157,237,435
|
|
|
|
|
|
Ending balance at Dec. 31, 2021 |
$ 1,081,618
|
$ (1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
$ (1,545)
|
Ending balance (in shares) at Dec. 31, 2021 |
0
|
|
|
0
|
|
|
|
|
Beginning balance (in shares) at Nov. 08, 2021 |
|
|
53,045,510
|
|
|
|
|
|
Beginning balance at Nov. 08, 2021 |
$ 252,443
|
|
$ 53,046
|
$ 0
|
229,500
|
(2,938)
|
(27,165)
|
|
Beginning balance (in shares) at Nov. 08, 2021 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Net income (loss) |
$ (682,149)
|
|
|
|
|
|
(682,149)
|
|
Ending balance (in shares) at Dec. 31, 2021 |
157,237,435
|
|
157,237,435
|
|
|
|
|
|
Ending balance at Dec. 31, 2021 |
$ 1,081,618
|
(1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
(1,545)
|
Ending balance (in shares) at Dec. 31, 2021 |
0
|
|
|
0
|
|
|
|
|
Beginning balance (in shares) at Nov. 09, 2021 |
|
|
156,937,410
|
|
|
|
|
|
Beginning balance at Nov. 09, 2021 |
$ 1,476,881
|
|
$ 156,937
|
$ 0
|
1,376,312
|
0
|
(56,368)
|
|
Beginning balance (in shares) at Nov. 09, 2021 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Sale of ordinary shares issued to Director Subscribers (in shares) |
|
|
200,000
|
|
|
|
|
|
Sale of ordinary shares issued to Director Subscribers |
2,000
|
|
$ 200
|
|
1,800
|
|
|
|
Share-based compensation |
290,846
|
|
|
|
290,846
|
|
|
|
Ordinary shares issued related to share-based compensation (in shares) |
|
|
100,000
|
|
|
|
|
|
Ordinary shares issued related to share-based compensation |
1,175
|
|
$ 100
|
|
1,075
|
|
|
|
Warrants exercised (in shares) |
|
|
25
|
|
|
|
|
|
Net income (loss) |
(682,149)
|
|
|
|
|
|
(682,149)
|
|
Other comprehensive income (loss) |
$ (7,135)
|
|
|
|
|
(7,135)
|
|
|
Ending balance (in shares) at Dec. 31, 2021 |
157,237,435
|
|
157,237,435
|
|
|
|
|
|
Ending balance at Dec. 31, 2021 |
$ 1,081,618
|
(1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
(1,545)
|
Ending balance (in shares) at Dec. 31, 2021 |
0
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
$ 4,963
|
|
|
|
4,963
|
|
0
|
|
Net income (loss) |
36,963
|
|
|
|
0
|
|
36,963
|
|
Ending balance (in shares) at Mar. 31, 2022 |
|
|
163,234,542,000
|
|
|
|
|
|
Ending balance at Mar. 31, 2022 |
$ 1,137,982
|
|
$ 163,235
|
$ 0
|
1,683,310
|
(7,009)
|
(701,554)
|
|
Ending balance (in shares) at Mar. 31, 2022 |
|
|
|
0
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2021 |
157,237,435
|
|
157,237,435
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
$ 1,081,618
|
(1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
(1,545)
|
Beginning balance (in shares) at Dec. 31, 2021 |
0
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Net income (loss) |
$ 45,890
|
|
|
|
|
|
|
|
Ending balance (in shares) at Jun. 30, 2022 |
162,637,029
|
|
163,234,542,000
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
$ 1,128,963
|
|
$ 163,235
|
$ (5,008)
|
1,686,743
|
(23,380)
|
(692,627)
|
|
Ending balance (in shares) at Jun. 30, 2022 |
597,513
|
|
|
597,513,000
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2021 |
157,237,435
|
|
157,237,435
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
$ 1,081,618
|
(1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
(1,545)
|
Beginning balance (in shares) at Dec. 31, 2021 |
0
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Net income (loss) |
$ 152,117
|
|
|
|
|
|
|
|
Ending balance (in shares) at Sep. 30, 2022 |
162,316,326
|
|
163,234,542,000
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
$ 1,213,600
|
|
$ 163,235
|
$ (7,572)
|
1,685,898
|
(41,561)
|
(586,400)
|
|
Ending balance (in shares) at Sep. 30, 2022 |
918,216
|
|
|
918,216,000
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2021 |
157,237,435
|
|
157,237,435
|
|
|
|
|
|
Beginning balance at Dec. 31, 2021 |
$ 1,081,618
|
$ (1,545)
|
$ 157,237
|
$ 0
|
1,670,033
|
(7,135)
|
(738,517)
|
$ (1,545)
|
Beginning balance (in shares) at Dec. 31, 2021 |
0
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
$ 14,649
|
|
|
|
14,649
|
|
|
|
Ordinary shares issued related to share-based compensation (in shares) |
|
|
5,952,992
|
|
|
|
|
|
Ordinary shares issued related to share-based compensation |
0
|
|
$ 5,954
|
|
(5,954)
|
|
|
|
Liability portion of founders advisory fees - related party reclassified to additional paid in capital |
19,568
|
|
|
|
19,568
|
|
|
|
Warrants exercised (in shares) |
|
|
44,115
|
|
|
|
|
|
Warrants exercised |
$ 529
|
|
$ 44
|
|
485
|
|
|
|
Ordinary shares repurchased (in shares) |
6,436,736
|
|
|
6,436,736
|
|
|
|
|
Ordinary shares repurchased |
$ (49,341)
|
|
|
$ (49,341)
|
|
|
|
|
Net income (loss) |
91,758
|
|
|
|
|
|
91,758
|
|
Other comprehensive income (loss) |
$ (18,336)
|
|
|
|
|
(18,336)
|
|
|
Ending balance (in shares) at Dec. 31, 2022 |
156,797,806
|
|
163,234,542
|
|
|
|
|
|
Ending balance at Dec. 31, 2022 |
$ 1,138,900
|
|
$ 163,235
|
$ (49,341)
|
1,698,781
|
(25,471)
|
(648,304)
|
|
Ending balance (in shares) at Dec. 31, 2022 |
6,436,736
|
|
|
6,436,736
|
|
|
|
|
Beginning balance (in shares) at Mar. 31, 2022 |
|
|
163,234,542,000
|
|
|
|
|
|
Beginning balance at Mar. 31, 2022 |
$ 1,137,982
|
|
$ 163,235
|
$ 0
|
1,683,310
|
(7,009)
|
(701,554)
|
|
Beginning balance (in shares) at Mar. 31, 2022 |
|
|
|
0
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
3,433
|
|
|
|
3,433
|
|
|
|
Ordinary shares repurchased (in shares) |
|
|
|
597,513,000
|
|
|
|
|
Ordinary shares repurchased |
(5,008)
|
|
|
$ (5,008)
|
|
|
|
|
Net income (loss) |
8,927
|
|
|
|
|
|
8,927
|
|
Other comprehensive income (loss) |
$ (16,371)
|
|
|
|
|
(16,371)
|
|
|
Ending balance (in shares) at Jun. 30, 2022 |
162,637,029
|
|
163,234,542,000
|
|
|
|
|
|
Ending balance at Jun. 30, 2022 |
$ 1,128,963
|
|
$ 163,235
|
$ (5,008)
|
1,686,743
|
(23,380)
|
(692,627)
|
|
Ending balance (in shares) at Jun. 30, 2022 |
597,513
|
|
|
597,513,000
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
Share-based compensation |
$ (845)
|
|
|
|
(845)
|
|
|
|
Ordinary shares repurchased (in shares) |
|
|
|
320,703,000
|
|
|
|
|
Ordinary shares repurchased |
(2,564)
|
|
|
$ (2,564)
|
|
|
|
|
Net income (loss) |
106,227
|
|
|
|
|
|
106,227
|
|
Other comprehensive income (loss) |
$ (18,181)
|
|
|
|
|
(18,181)
|
|
|
Ending balance (in shares) at Sep. 30, 2022 |
162,316,326
|
|
163,234,542,000
|
|
|
|
|
|
Ending balance at Sep. 30, 2022 |
$ 1,213,600
|
|
$ 163,235
|
$ (7,572)
|
$ 1,685,898
|
$ (41,561)
|
$ (586,400)
|
|
Ending balance (in shares) at Sep. 30, 2022 |
918,216
|
|
|
918,216,000
|
|
|
|
|